Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Research Protocols

Date Submitted: Nov 12, 2026
Open Peer Review Period: Nov 16, 2026 - Jan 11, 2027
(currently open for review)

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Stage-Matched Multimodal Home Rehabilitation Compared With Standardized Usual Conservative Care for Adults With de Quervain Tenosynovitis: Protocol for a Prospective, Assessor-Blinded, Parallel-Group Randomized Controlled Trial

  • ZiXuan Tendinitis Treatment Research Group

ABSTRACT

Background:

De Quervain tenosynovitis (DQT) is stenosing inflammation of the first dorsal extensor compartment of the wrist. Network meta-analysis evidence ranks local corticosteroid injection with short-term immobilization highly for short-term relief, whereas conservative, nonpharmacological home programs remain incompletely characterized, especially when treatment intensity is matched to the clinical stage [1-4]. Patients spend most recovery time outside clinics, and existing home guidance is often single-modality, undifferentiated by inflammatory stage, and without standardized dosing or objective adherence records.

Objective:

This protocol describes a prospective superiority randomized controlled trial (RCT) comparing a stage-matched multimodal home rehabilitation program (MSMRP) with standardized usual conservative care (UCC). The primary objective is to compare between-group change in the Patient-Rated Wrist Evaluation (PRWE) total score from baseline to week 12. Secondary objectives are to compare pain, upper-extremity function, grip strength, range of motion, adherence, rescue treatment, and adverse events; to document process measures; and to provide a preregistered statistical plan for a definitive efficacy assessment.

Methods:

Adults with clinician-confirmed DQT will be randomized 1:1 through computer-generated, stratified, permuted-block allocation. Stratification factors are recruitment site and symptom duration (<=2 weeks vs >2 weeks). Outcome assessors and the data analyst are blinded; participants and program providers cannot be blinded to the active program and this limitation is declared explicitly. The MSMRP combines stage-adapted thermotherapy, transcutaneous acupoint electrical stimulation at LI5, LU7, LI4, and LU10, a standardized topical conductive adjunct, audio accompaniment, and progressive home exercise. The UCC arm operationalizes the common outpatient treatment hierarchy: patient education and activity modification, contraindication-screened topical or oral analgesia, a standardized hand exercise program, matched follow-up contact, and a prespecified pathway to clinician-directed ultrasound-guided corticosteroid injection when improvement is inadequate; escalation injection is a routine clinical decision recorded under ITT rather than a randomized assignment. Assessments occur at baseline and weeks 2, 4, 8, and 12; a safety and recurrence follow-up occurs at week 24. The primary analysis will use an intention-to-treat mixed model for repeated measurements. The planned sample size uses a planning anchor of PRWE between-group difference 11.5 points, conservative planning standard deviation 18 points, two-sided alpha 0.05, and 80% power, inflated by 15% for attrition; the variance assumption will be transparently labeled and revised only on prespecified blinded internal records before the primary analysis.

Results:

Participant recruitment has not commenced and no clinical efficacy data have been collected. This manuscript therefore reports the design, eligibility, intervention dosing, planned analyses, governance, and expected reporting outputs rather than observed treatment effects. A parallel section documents only non-efficacy formative work (engineering self-checks, a preference survey, and a preliminary staging-tool review); none of these items constitute clinical evidence.

Conclusions:

The trial will generate preregistered, assessor-blinded evidence on whether a standardized stage-matched home rehabilitation package improves patient-reported pain and function in DQT relative to usual conservative care. If positive, subsequent component-level factorial studies will be required because the present composite intervention cannot isolate the contribution of any single component. The protocol is intended as a transparent design record and should not be read as evidence of efficacy.


 Citation

Please cite as:

Tendinitis Treatment Research Group Z

Stage-Matched Multimodal Home Rehabilitation Compared With Standardized Usual Conservative Care for Adults With de Quervain Tenosynovitis: Protocol for a Prospective, Assessor-Blinded, Parallel-Group Randomized Controlled Trial

JMIR Preprints. 12/11/2026:116849

DOI: 10.2196/preprints.116849

URL: https://preprints.jmir.org/preprint/116849

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.